IRIS
ARMENI, PATRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.799
NA - Nord America 3.118
AS - Asia 1.587
SA - Sud America 117
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 10.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.954
IT - Italia 2.668
GB - Regno Unito 785
IE - Irlanda 718
CN - Cina 427
SG - Singapore 404
UA - Ucraina 345
DE - Germania 286
RU - Federazione Russa 200
HK - Hong Kong 191
SE - Svezia 159
CA - Canada 150
TR - Turchia 144
FI - Finlandia 138
FR - Francia 116
VN - Vietnam 112
NL - Olanda 109
BR - Brasile 99
KR - Corea 76
IN - India 63
CZ - Repubblica Ceca 59
BG - Bulgaria 48
IL - Israele 42
BE - Belgio 40
ID - Indonesia 40
ES - Italia 22
AT - Austria 19
CH - Svizzera 18
RO - Romania 13
DK - Danimarca 12
IR - Iran 10
PL - Polonia 10
PH - Filippine 9
CL - Cile 8
EU - Europa 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 6
JP - Giappone 6
JO - Giordania 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
AU - Australia 4
GE - Georgia 4
GR - Grecia 4
KG - Kirghizistan 4
MY - Malesia 4
PA - Panama 4
PK - Pakistan 4
PT - Portogallo 4
SI - Slovenia 4
AR - Argentina 3
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
IQ - Iraq 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
MX - Messico 3
NO - Norvegia 3
ZA - Sudafrica 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
EE - Estonia 2
EG - Egitto 2
HU - Ungheria 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
PE - Perù 2
SA - Arabia Saudita 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BD - Bangladesh 1
BO - Bolivia 1
BT - Bhutan 1
DZ - Algeria 1
EC - Ecuador 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TM - Turkmenistan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 10.651
Salva come PNG Salva come JPEG
Città #
Dublin 717
Milan 574
Southend 532
Chandler 484
Jacksonville 275
Singapore 236
Ann Arbor 234
Rome 224
Hong Kong 190
Toronto 135
Dearborn 128
The Dalles 114
Dong Ket 104
New York 97
Beijing 95
Houston 93
Helsinki 91
Wilmington 80
Seoul 75
Modena 66
Lawrence 64
Boston 63
Boardman 62
Ashburn 57
Izmir 56
Naples 51
Los Angeles 46
Moscow 46
Redwood City 41
Redmond 39
Tel Aviv 39
Brussels 38
Jakarta 38
Florence 36
Munich 36
Bari 35
Mountain View 34
Bologna 33
Turin 33
Woodbridge 33
Casorate Primo 30
Seattle 30
Catania 26
Frankfurt am Main 26
Assago 24
Falkenstein 21
Genoa 21
Hefei 20
Brno 18
Duncan 18
Kunming 18
Nanjing 18
London 17
Amsterdam 16
Dallas 16
Busto Arsizio 13
Cagliari 13
Palombara Sabina 13
Parma 13
Torino 13
Washington 13
Bonndorf 12
Kocaeli 12
Pisa 12
Paris 11
Boydton 10
Fairfield 10
Melendugno 10
Palermo 10
São Paulo 10
Verona 10
Brescia 9
Düsseldorf 9
Fremont 9
Guangzhou 9
Jinan 9
Ottawa 9
Padova 9
Udine 9
Lappeenranta 8
Monza 8
Pescara 8
Prague 8
Ravenna 8
Vienna 8
Bucharest 7
Isernhagen-Süd 7
Reggio Emilia 7
Shanghai 7
Warsaw 7
Ancona 6
Berlin 6
Caserta 6
Casoria 6
Council Bluffs 6
Foggia 6
North Wales 6
Pavia 6
Pomezia 6
Renton 6
Totale 6.143
Salva come PNG Salva come JPEG
Nome #
Digitalizzazione nelle tecnologie per la salute: impatto sui livelli di governo del SSN 490
The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study 397
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 316
Politiche del farmaco ed impatto sulla spesa: gli effetti di quindici anni di decentramento nel SSN, con un focus sull’adozione di forme alternative di distribuzione dei farmaci 308
La spesa sanitaria: composizione ed evoluzione 278
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 267
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 255
I dispositivi medici in Italia: un settore, tanti mercati 236
Report n. 42 OSFAR (Osservatorio Farmaci) 190
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 185
L'acquisto di farmaci in Italia: l'effetto di approcci selettivi 182
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 177
Il governo regionale dell'assistenza farmaceutica e il suo impatto sulla spesa 177
Il governo dell'assistenza farmaceutica in Italia: possibili traiettorie di cambiamento 175
PHP3 the simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 174
La rendicontazione e la remunerazione dei farmaci. Finalità, struttura e gestione del File F in nove Regioni italiane 169
Il confronto dei sistemi sanitari in una prospettiva internazionale 163
Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation 162
Market access management by pharmaceutical companies in a complex environment: the Italian case study 161
The impact of HTA and procurement practices on the selection and prices of medical devices 156
A value-based revolution in health care: perspectives, challenges, and emerging approaches to defining and measuring the value of health care technologies 154
Diffusion without evidence: a study on high-risk medical devices 153
The future of Funds for Innovative Medicines: results from a Delphi Study 151
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 151
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis 148
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service 145
The impact of generic reference pricing in Italy, a decade on 141
Comparative effectiveness of Mitraclip plus medical therapy versus medical therapy alone in high-risk surgical patients: a comprehensive review 140
La spesa sanitaria: composizione ed evoluzione 138
L'adozione dell'innovazione tecnologica da parte degli ospedali italiani: un'analisi dei fattori endogeni 137
A meta-analysis of MitraClip combined with medical therapy versus medical therapy alone for treatment of mitral regurgitation in heart failure patients 137
The impact of generic reference pricing in Italy, a decade on 136
Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement) 134
Il confronto dei sistemi sanitari in una prospettiva internazionale 130
Il confronto dei sistemi sanitari in una prospettiva internazionale 128
When peers count: the effects on integrated type II diabetes care of communication within general practitioner-only subgroups in interprofessional primary care teams 127
La spesa sanitaria: composizione ed evoluzione 123
Cost-benefit analysis in health care: the case of bariatric surgery compared with diet 120
L'attività sperimentale sui dispositivi medici 119
The social burden and quality of life of patients with haemophilia in Italy 118
Cost-utility analysis of esketamine for patients with treatment resistant depression in Italy 118
Multi-professional primary care units: what affects the clinical performance of Italian general practitioners? 117
Il confronto dei sistemi sanitari in una prospettiva internazionale 115
Social/economic costs and quality of life in patients with haemophilia in Europe 114
Mobile health divide between clinicians and patients in cancer care: results from a cross-sectional international survey 114
I settori contigui alla sanità: struttura e performance delle imprese farmaceutiche, di dispositivi medici e delle farmacie in Italia 109
Digital Twins in healthcare: is it the beginning of a new era of evidence-based medicine? A critical review 108
The invisible costs of obstructive sleep apnea (OSA): systematic review and cost-of-illness analysis 108
Il settore dei dispositivi medici in Italia. L’impatto delle politiche pubbliche sulle performance delle imprese 108
La spesa sanitaria: composizione ed evoluzione 108
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service 107
What type of clinical evidence is needed to assess medical devices? 106
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 105
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe 104
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 102
Il confronto dei sistemi sanitari in una prospettiva internazionale 100
Social economic costs, health-related quality of life and disability in patients with Cri Du Chat syndrome 100
Implementation of value-based pricing for medicines 97
The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study 96
La spesa sanitaria: composizione ed evoluzione 96
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 92
La spesa sanitaria: composizione ed evoluzione 83
La spesa sanitaria: composizione ed evoluzione 82
La spesa sanitaria: composizione ed evoluzione 78
Variations in non-prescription drug consumption and expenditure: determinants and policy implications 76
La spesa sanitaria: composizione ed evoluzione 75
La spesa sanitaria: composizione ed evoluzione 74
Collecting physicians' preferences on medical devices: are we doing it right? Evidence from Italian orthopedists using 2 different stated preference methods 70
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 68
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case 67
La spesa sanitaria: composizione ed evoluzione 66
Politiche del farmaco: approfondimento sul Value Framework per i farmaci 58
The value of hearing aids for the Italian NHS: a cost-utility analysis 55
Percutaneous mitral valve repair vs. stand-alone medical therapy in patients with functional mitral regurgitation and heart failure 55
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention 54
Economic impact of a more extensive use of FENO testing on the Italian population with asthma 51
Reflections on the importance of cost of illness analysis in rare diseases: a proposal 48
La copertura vaccinale nelle regioni italiane. Un’analisi dell’eterogeneità 45
Use of resource modeling to quantify the organizational impact of subcutaneous formulations for the treatment of oncologic patients: the case of daratumumab in multiple myeloma 42
Cost-effectiveness analysis of HRD testing for previously treated patients with advanced ovarian cancer in Italy 36
Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries 31
Individual and team performanc: issues around the role of attributes and relationships among peers 30
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe 28
Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment 23
L’evoluzione del finanziamento dei farmaci in Italia 18
The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States 4
Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes 3
Exploring the potential of digital therapeutics: an assessment of progress and promise 3
Economic evaluation of two therapeutic sequences in the first-line treatment of moderate to severe active ulcerative rectocolitis in Italy 3
Totale 10.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020198 0 0 0 0 0 0 0 0 0 0 74 124
2020/20211.206 63 88 41 116 121 81 105 60 132 103 108 188
2021/2022935 68 180 36 41 66 12 31 174 41 47 105 134
2022/20232.347 119 127 58 176 153 189 63 101 977 94 165 125
2023/20241.807 104 97 123 89 167 177 105 279 99 136 211 220
2024/20252.095 138 36 170 123 209 157 162 165 571 286 78 0
Totale 10.898